Autoinjectors Market is Expected to Reach $5.73 Billion by 2027: Allied Market Research

Increase in prevalence of anaphylaxis, rise in preference among patients to choose self-administration of injections, and high-end technological advancements in autoinjectors drive the growth of the global autoinjector market. By end user, the home care settings segment generated the major share in 2019. By geography, on the other hand, North America appeared as the highest revenue holder in the same year.


Portland, OR, Oct. 05, 2020 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the Autoinjectors Market size was estimated at $1.50 billion in 2019 and is expected to hit $5.73 billion by 2027, registering a CAGR of 18.1% from 2020 to 2027. The report provides a detailed analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive landscape, and evolving market trends.

Request for Detailed COVID-19 Impact Sample Report at: https://www.alliedmarketresearch.com/request-for-customization/1461?reqfor=covid

Increase in prevalence of anaphylaxis, rise in preference among patients to choose self-administration of injections, and high-end technological advancements in autoinjectors drive the growth of the global autoinjectors market. On the other hand, availability of alternative treatment options such as general injections and oral tablets curtail down the growth to certain extent. Nevertheless, patent expiry of biologics to fuel biosimilar demands is anticipated to pave the way for lucrative opportunities for the frontrunners in the sector.

Covid-19 scenario-

  • Covid-19 has increased the demand for autoinjectors that are a perfect fit to be used in the home environment.
  • Simultaneously, the preventive measures taken during the pandemic have not been applicable to the healthcare industry at large, thus leaving the global market for autoinjectors unaffected.

The global autoinjetors market is analyzed across type, application, end-user, and region. By type, the disposable autoinjectors segment contributed to more than two-thirds of the total market revenue in 2019 and is anticipated to lead the trail from 2020 to 2027. The same segment is also expected to portray the fastest CAGR of 18.4% during the study period.

By end user, the home care settings segment accounted for more than three-fifths of the total market share in 2019 and is expected to rule the roost by 2027. The same segment would also grow at the fastest CAGR of 18.3% throughout the forecast period.

For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/1461

By geography, North America held the major in 2019, holding more than two-fifths of the global market. Simultaneously, Asia-Pacific would register the fastest CAGR of 18.6% till 2027. The other regions covered in the study include LAMEA and Europe.

The key market players analyzed in the global autoinjectors market report include Becton Dickinson and Company, Johnson and Johnson, Mylan N.V., Teva Pharmaceutical Industries Ltd., Johnson and Johnson, Novartis AG, SHL Medical, Antares Pharma, Eli Lilly and Company, Ypsomed AG, and Amgen. These market players have embraced several strategies including partnership, expansion, collaboration, joint ventures, and others to highlight their prowess in the industry.

Avenue Basic Plan | Library Access | 1 Year Subscription |

Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.

Avenue Library Subscription | Request for 14 days free trial of before buying: https://www.alliedmarketresearch.com/avenue/trial/starter

Get more information: https://www.alliedmarketresearch.com/library-access


Similar Reports:

OVD Market - Global Opportunity Analysis and Industry Forecast, 2020–2026

Menstrual Cup Market - Global Opportunity Analysis and Industry Forecast, 2019-2026

Drug Discovery Market - Global Opportunity Analysis and Industry Forecast, 2019-2026

Pharmacogenomics Market Global Opportunity Analysis and Industry Forecast, 2019–2026

U.S. Intraoperative Neuromonitoring Market - Opportunity Analysis and Industry Forecast, 2019–2026

Gene Expression Market - Global Opportunity Analysis and Industry Forecast, 2019–2026

Safety Needles Market - Global Opportunity Analysis and Industry Forecast, 2019–2026


About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

 

Contact Data